We identified key metabolic pathways, including the novel finding of citric acid elevation and its interaction with the MIF gene, potential diagnostic biomarkers, as well as therapeutic targets, which may help guide future research and clinical management of lung cancer. The gene discussed is MIF; the disease is lung carcinoma.